Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
medical device
|
| gptkbp:developedBy |
gptkb:Nano_Precision_Medical
|
| gptkbp:enables |
long-term subcutaneous drug release
|
| https://www.w3.org/2000/01/rdf-schema#label |
NanoPortal implant
|
| gptkbp:implantation_site |
subcutaneous tissue
|
| gptkbp:legalStatus |
clinical trials
|
| gptkbp:mechanismOfAction |
nano-porous membrane
|
| gptkbp:targeted_condition |
gptkb:type_2_diabetes
chronic diseases |
| gptkbp:usedFor |
drug delivery
continuous monitoring |
| gptkbp:bfsParent |
gptkb:Nano_Precision_Medical
|
| gptkbp:bfsLayer |
7
|